OCCHealth CareCompany Update3 Nov 20263 November 2026· 2 min read
Orthocell (ASX: OCC) Gains U.S. Option as PearlBone Secures FDA Clearance
Orthocell’s strategic partner Marine Biomedical has secured U.S. FDA clearance for PearlBone. Orthocell owns 12% of the company and holds a first right of refusal over global distribution rights.